Package Insert: Information for the User
Aripiprazol Vir 15 mg Tablets EFG
Read this package insert carefully before starting to take this medication, as it contains important information for you.
Aripiprazol Vir belongs to a group of medications known as antipsychotics.
It is used to treat adults and adolescents 15 years of age or older who suffer from a condition characterized by symptoms such as hearing, seeing, and feeling things that do not exist, distrust, false beliefs, incoherent speech, and monotony of emotional and behavioral state. People in this state may also feel depressed, guilty, restless, or tense.
Aripiprazol is used to treat adults and adolescents 13 years of age or older who suffer from a disorder characterized by symptoms such as feeling euphoric, having excessive energy, needing less sleep than usual, speaking very quickly with flight of ideas, and sometimes, severe irritability. In adults, it also prevents this situation in patients who have responded to treatment with aripiprazol.
Warnings and precautions
Consult your doctor before starting to take Aripiprazol Vir.
There have been cases of patients who experience suicidal thoughts and behaviors during treatment with aripiprazol. Inform your doctor immediately if you have thoughts or feelings of harming yourself.
Before starting treatment with Aripiprazol Vir, tell your doctor if you have:
If you notice that you are gaining weight, developing unusual movements, experiencing drowsiness that interferes with your normal daily activities, having difficulty swallowing, or experiencing allergic symptoms, please inform your doctor.
If you have dementia (loss of memory and other mental abilities), you or the person caring for you or a family member should inform your doctor if you have ever had a stroke or "mini" stroke.
Tell your doctor immediately if you have thoughts or feelings of harming yourself. There have been cases of patients who experience suicidal thoughts and behaviors during treatment with aripiprazol.
Tell your doctor immediately if you notice numbness or stiffness of the muscles with high fever, sweating, changes in mental state, or a very fast or irregular heartbeat.
Your doctor may consider adjusting or interrupting the dose.
Aripiprazol may cause drowsiness, a drop in blood pressure when standing up, dizziness, and changes in the ability to move and maintain balance, which could lead to falls. You should be cautious, especially if you are an elderly patient and have some weakness.
Children and adolescents
Do not use this medicine in children and adolescents under 13 years of age. The safety and effectiveness of this medicine in these patients are unknown.
Other medicines and Aripiprazol Vir
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine, including those purchased without a prescription.
Medicines that lower blood pressure: aripiprazol may increase the effect of medicines used to lower blood pressure. Make sure to inform your doctor if you are using any medicine to control blood pressure.
If you are taking this medicine with any other medicine, it may mean that your doctor needs to change your dose of aripiprazol or the dose of the other medicine. It is especially important to mention to your doctor if you are taking:
These medicines may increase the risk of adverse effects or reduce the effect of aripiprazol; if you observe any unusual symptoms when taking any of these medicines with aripiprazol, you should inform your doctor.
These medicines may increase the risk of adverse effects; if you observe any unusual symptoms when taking any of these medicines with aripiprazol, you should inform your doctor.
Taking Aripiprazol Vir with food, drinks, and alcohol
This medicine can be taken regardless of meals.
Alcohol consumption should be avoided.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, or if you think you may be pregnant, consult your doctor or pharmacist before using this medicine.
The following symptoms may occur in newborn babies, from mothers who have been treated with aripiprazol in the last trimester of pregnancy (last three months of pregnancy): tremors, stiffness, and/or muscle weakness, drowsiness, agitation, breathing problems, and difficulty feeding. If your baby develops any of these symptoms, you should contact your doctor.
Driving and operating machinery
During treatment with this medicine, you may feel dizzy or have vision problems (see section 4).
This should be taken into account when requiring maximum attention, for example, when driving or operating machinery.
Aripiprazol Vir contains Lactose
If your doctor has told you that you have an intolerance to certain sugars, consult with him before taking this medicine.
The recommended dose for adults is 15 mg once a day.However, your doctor may prescribe lower and higher doses up to a maximum of 30 mg once a day.
Use in children and adolescents
This medication should be started at a low dose with the oral solution (liquid) at a low dose. Gradually the dose may be increased tothe recommended dose for adolescents of 10 mg once a day. However, your doctor may prescribe lower or higher doses up to a maximum of 30 mg once a day.
If you estimate that the action of aripiprazole is too strong or too weak, inform your doctor or pharmacist.
Try to take the aripiprazole tablet at the same time every day. It does not matter if you take it with or without food. Always take the tablets with water and swallow them whole.
Even if you feel better, do not alter or interrupt the daily dose of aripiprazole without consulting your doctor first.
If you take more Aripiprazol Vir than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicological Information Service, phone: 91.562.04.20 indicating the medication and the amount ingested.
Patients who have taken too much aripiprazole have experienced the following symptoms:
Other symptoms may include:
Contact your doctor or nearest hospital immediately if you experience any of the above symptoms.
If you forgot to take Aripiprazol Vir
If you forget a dose, take the missed dose as soon as you remember, but do not take a double dose to compensate for the missed dose.
If you stop taking Aripiprazol Vir
Do not stop treatment just because you feel better. It is essential that you continue taking aripiprazole for the time your doctor has indicated.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
Frequent side effects (may affect up to 1 in 10 patients):
Less frequent side effects (may affect up to 1 in 100 patients):
The following side effects have been reported during the post-marketing phase of oral aripiprazole butthe frequency of occurrence is unknown
Inform your doctor if you experience any of these behaviors; he will explain how to manage or reduce the symptoms.
In elderly patients with dementia, there have been reported a higher number of fatal cases while taking aripiprazole. Additionally, cases of stroke or "mini" stroke have been reported.
Other side effects in children and adolescents
Adolescents aged 13 years or older experienced side effects similar in frequency and type to those of adults, except for drowsiness, involuntary spasms or contractions, restlessness, and fatigue, which were very frequent (affected more than 1 in 10 patients), and upper abdominal pain, dry mouth, increased heart rate, weight gain, increased appetite, muscle fasciculations, involuntary movements of the limbs, and dizziness, especially when getting up from lying or sitting, which were frequent (affected up to 1 in 100 patients).
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through the Spanish System for the Vigilance of Medicines for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through drains or in the trash. Dispose of the packaging and medications you no longer need at the SIGRE collection point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. By doing so, you will help protect the environment.
Composition of Aripiprazol Vir
- The active ingredient is aripiprazol. Each tablet contains 15 mg of aripiprazol.
- The other components are potato starch glycolate, microcrystalline cellulose, lactose monohydrate, hydroxypropyl cellulose, magnesium stearate and yellow iron oxide (E172)
Appearance of the product and contents of the package
Rounded tablets (approximately 7 mm) and yellow. With possible darker points, engraved with “ARZ” and 15 on one side.
Single-dose blister pack of aluminum (OPA/Aluminum/PVC/Aluminum) in boxes of 10, 14, 28, 30, 49, 50, 56, 98 or 100 tablets.
Only some package sizes may be marketed.
Holder of the marketing authorization and responsible manufacturer
Holder of the marketing authorization
Industria Química y Farmacéutica VIR, S.A.
C/ Laguna 66-70, Polígono Industrial URTINSA II
28923 Alcorcón (Madrid)
Spain
Responsible manufacturers
Industria Química y Farmacéutica VIR, S.A.
C/ Laguna 66-70, Polígono Industrial URTINSA II
28923 Alcorcón (Madrid)
Spain
or
Synthon S.R.O
Brnenska 32/cp. 597 67801
Blansko, Czech Republic
or
Synthon Hispania S.L
Castello 1, Polígono Las Salinas
Sant De Llobregat (Barcelona), Spain
This medicine is authorized in the member states of the European Economic Area with the following names:
NetherlandsAripiprazol Synthon 15 mg, tablets
AustriaAripiprazol Aristo 15 mg Tablets
FinlandAripiprazole Avansor15 mg tablets
SpainAripiprazol Vir 15 mg tablets
Last review date of this leaflet: May 2023
The detailed information of this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) https://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.